AKT1 and vitiligo: The therapeutic effect of apigenin on vitiligo may be related to enhancing antioxidant activity, activating Nrf2 pathway, inhibiting the phosphorylation of p38, JNK and Akt, and activating K+ - Cl– cotransport (KCC).